Sign in
4

Changes in Ownership

Akebia Therapeutics, Inc. Filed Acc 0001562180-16-003207

SVP, Chief Business Officer sold 1,401 shares at $8.95 ($12,546)

From the SEC's structured data for this filing

Trades in this filing

Dahan Michel · SVP, Chief Business Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-10-01 Sale : show line 1 in the form −1,401 $8.95 $12,546 72,153 D
Open-market sales · 1,401 sh · avg $8.95 · $12,546
Loading xslF345X03/primarydocument.xml…